CARDIOVASCULAR DISEASE References

1.            Alvarez GG, and Ayas NT. The impact of daily sleep duration on health: a review of the literature. Prog Cardiovasc Nurs 19: 56-59, 2004.

2.            Arzt M, Young T, Finn L, Skatrud JB, and Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 172: 1447-1451, 2005.

3.            Bassetti CL, Milanova M, and Gugger M. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 37: 967-972, 2006.

4.            Bonekat HW, and Hardin KA. Severe upper airway obstruction during sleep. Clin Rev Allergy Immunol 25: 191-210, 2003.

5.            Browne HA, Adams L, Simonds AK, and Morrell MJ. Ageing does not influence the sleep-related decrease in the hypercapnic ventilatory response. Eur Respir J 21: 523-529, 2003.

6.            Burgess KR. Central sleep apnoea and heart failure (part II). Respirology 3: 1-11, 1998.

7.            Casillas JM, Gremeaux V, Damak S, Feki A, and Perennou D. Exercise training for patients with cardiovascular disease. Ann Readapt Med Phys 50: 403-418, 386-402, 2007.

8.            Chasens ER. Obstructive sleep apnea, daytime sleepiness, and type 2 diabetes. Diabetes Educ 33: 475-482, 2007.

9.            Chiariello M, and Perrone-Filardi P. Pathophysiology of heart failure. Miner Electrolyte Metab 25: 6-10, 1999.

10.          Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, and Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25: 735-741, 2004.

11.          Devereux RB, Roman MJ, Paranicas M, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Rodeheffer RJ, Cowan LD, and Howard BV. A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study. Am Heart J 141: 439-446, 2001.

12.          Dubnov G, Brzezinski A, and Berry EM. Weight control and the management of obesity after menopause: the role of physical activity. Maturitas 44: 89-101, 2003.

13.            Figueroa MS, and Peters JI. Congestive heart failure: Diagnosis, pathophysiology, therapy, and implications for respiratory care. Respir Care 51: 403-412, 2006.

14.            Gabrielsen A, Sorensen VB, Pump B, Galatius S, Videbaek R, Bie P, Warberg J, Christensen NJ, Wroblewski H, Kastrup J, and Norsk P. Cardiovascular and neuroendocrine responses to water immersion in compensated heart failure. Am J Physiol Heart Circ Physiol 279: H1931-1940, 2000.

15.           Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, and Somers VK. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49: 565-571, 2007.

16.           Gami AS, and Somers VK. Implications of Obstructive Sleep Apnea for Atrial Fibrillation and Sudden Cardiac Death. J Cardiovasc Electrophysiol 2008.

17.            Gehlbach BK, and Geppert E. The pulmonary manifestations of left heart failure. Chest 125: 669-682, 2004.

18.            Gilbert PA, and Khokhar S. Changing dietary habits of ethnic groups in Europe and implications for health. Nutr Rev 66: 203-215, 2008.

19.            Grassi G, Seravalle G, Quarti-Trevano F, Scopelliti F, Dell'Oro R, Bolla G, and Mancia G. Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms. Hypertension 49: 535-541, 2007.

20.            Gunnarsson OT, and Judge JO. Exercise at midlife: how and why to prescribe it for sedentary patients. Geriatrics 52: 71-72, 77-80; quiz 81, 1997.

21.            Gur S, Kadowitz PJ, and Hellstrom WJ. Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction : implications for sexual dysfunction. Drugs 68: 209-229, 2008.

22.            Guyenet PG. Neural structures that mediate sympathoexcitation during hypoxia. Respir Physiol 121: 147-162, 2000.

23.            Hall MJ, Xie A, Rutherford R, Ando S, Floras JS, and Bradley TD. Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med 154: 376-381, 1996.

24.            Happe S. Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management. Drugs 63: 2725-2737, 2003.

25.            Hollenberg NK. Considerations for management of fluid dynamic issues associated with thiazolidinediones. Am J Med 115 Suppl 8A: 111S-115S, 2003.

26.            Jantzen JP. Prevention and treatment of intracranial hypertension. Best Pract Res Clin Anaesthesiol 21: 517-538, 2007.

27.            Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 341: 949-954, 1999.

28.            Klingelhofer J, and Sander D. Cardiovascular consequences of clinical stroke. Baillieres Clin Neurol 6: 309-335, 1997.

29.            LeVay AJ, and Kveton JF. Relationship between obesity, obstructive sleep apnea, and spontaneous cerebrospinal fluid otorrhea. Laryngoscope 118: 275-278, 2008.

30.            Makaritsis KP, Liakopoulos V, Leivaditis K, Eleftheriadis T, and Stefanidis I. Adaptation of renal function in heart failure. Ren Fail 28: 527-535, 2006.

31.            Manthey J, Dietz R, Opherk D, Osterziel KJ, Leinberger H, and Kubler W. Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness. Am J Cardiol 70: 224-228, 1992.

32.            Marin JM, Carrizo SJ, Vicente E, and Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365: 1046-1053, 2005.

33.            McEwen BS. Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load. Metabolism 55: S20-23, 2006.

34.            McNab AA. The eye and sleep apnea. Sleep Med Rev 11: 269-276, 2007.

35.            McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 97 Suppl 2: 23-28; discussion 44-25, 2006.

36.            Moulik PK, and Hardy KJ. Hypertension, anti-hypertensive drug therapy and erectile dysfunction in diabetes. Diabet Med 20: 290-293, 2003.

37.            Mozaffarian D, Marfisi R, Levantesi G, Silletta MG, Tavazzi L, Tognoni G, Valagussa F, and Marchioli R. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors. Lancet 370: 667-675, 2007.

38.            Narkiewicz K, and Somers VK. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 177: 385-390, 2003.

39.            Naughton M, Benard D, Tam A, Rutherford R, and Bradley TD. Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis 148: 330-338, 1993.

40.            Ness-Abramof R, and Apovian CM. Drug-induced weight gain. Drugs Today (Barc) 41: 547-555, 2005.

41.            Norman D, and Loredo JS. Obstructive sleep apnea in older adults. Clin Geriatr Med 24: 151-165, ix, 2008.

42.            Papatsoris AG, and Korantzopoulos PG. Hypertension, antihypertensive therapy, and erectile dysfunction. Angiology 57: 47-52, 2006.

43.           Patel C, Wyne KL, and McGuire DK. Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence? Diab Vasc Dis Res 2: 61-66, 2005.

44.            Piechota G, Malkiewicz J, and Karwat ID. [Obesity as a cause and result of disability]. Przegl Epidemiol 59: 155-161, 2005.

45.           Pijl H, and Meinders AE. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf 14: 329-342, 1996.

46.           Pillar G, and Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 31 Suppl 2: S303-309, 2008.

47.            Provini F, Vetrugno R, Lugaresi E, and Montagna P. Sleep-related breathing disorders and headache. Neurol Sci 27 Suppl 2: S149-152, 2006.

48.            Punjabi NM, and Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99: 1998-2007, 2005.

49.            Quaranta AJ, D'Alonzo GE, and Krachman SL. Cheyne-Stokes respiration during sleep in congestive heart failure. Chest 111: 467-473, 1997.

50.            Ropper AH, and Shafran B. Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol 41: 26-29, 1984.

51.            Rosen RC. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia. Curr Opin Urol 16: 11-19, 2006.

52.            Saaresranta T, and Polo O. Does leptin link sleep loss and breathing disturbances with major public diseases? Ann Med 36: 172-183, 2004.

53.            Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 119: S47-53, 2006.

54.            Schweiger TA, and Zdanowicz MM. Vasopressin-receptor antagonists in heart failure. Am J Health Syst Pharm 65: 807-817, 2008.

55.          Sica DA. Sodium and water retention in heart failure and diuretic therapy: basic mechanisms. Cleve Clin J Med 73 Suppl 2: S2-7; discussion S30-33, 2006.

56.          Strohl KP. Diabetes and sleep apnea. Sleep 19: S225-228, 1996.

57.          Strohl KP, Boehm KD, Denko CW, Novak RD, and Decker MJ. Biochemical morbidity in sleep apnea. Ear Nose Throat J 72: 34, 39-41, 1993.

58.          Sulit L, Storfer-Isser A, Kirchner HL, and Redline S. Differences in polysomnography predictors for hypertension and impaired glucose tolerance. Sleep 29: 777-783, 2006.

59.            Tilkian AG, Guilleminault C, Schroeder JS, Lehrman KL, Simmons FB, and Dement WC. Hemodynamics in sleep-induced apnea. Studies during wakefulness and sleep. Ann Intern Med 85: 714-719, 1976.

60.            Tkacova R, Niroumand M, Lorenzi-Filho G, and Bradley TD. Overnight shift from obstructive to central apneas in patients with heart failure: role of PCO2 and circulatory delay. Circulation 103: 238-243, 2001.

61.           Topor ZL, Johannson L, Kasprzyk J, and Remmers JE. Dynamic ventilatory response to CO(2) in congestive heart failure patients with and without central sleep apnea. J Appl Physiol 91: 408-416, 2001.

62.          Toth C, Martinez J, and Zochodne DW. RAGE, diabetes, and the nervous system. Curr Mol Med 7: 766-776, 2007.

63.            Tremel F, Pepin JL, Veale D, Wuyam B, Siche JP, Mallion JM, and Levy P. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 20: 1201-1209, 1999.

64.            Trenell MI, Marshall NS, and Rogers NL. Sleep and metabolic control: waking to a problem? Clin Exp Pharmacol Physiol 34: 1-9, 2007.

65.            Varela-Moreiras G. Controlling obesity: what should be changed? Int J Vitam Nutr Res 76: 262-268, 2006.

66.            Vgontzas AN, Bixler EO, and Chrousos GP. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med 254: 32-44, 2003.

67.            Whitmer RA. Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep 7: 373-380, 2007.

68.            Wofford MR, and King DS. Relationship between antihypertensive drugs and metabolic syndrome. Metab Syndr Relat Disord 2: 308-314, 2004.

69.           Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, and Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353: 2034-2041, 2005.

70.           Yun AJ, Lee PY, and Bazar KA. Autonomic dysregulation as a basis of cardiovascular, endocrine, and inflammatory disturbances associated with obstructive sleep apnea and other conditions of chronic hypoxia, hypercapnia, and acidosis. Med Hypotheses 62: 852-856, 2004.